论文部分内容阅读
安得克斯公司开发控释普药美国开发口服控释给药系统的安得克斯公司（Ａｎｄｒｘ）计划在１９９４年下半年和１９９５年第一季度提交７～１０个控释系统普药的新药申请。该公司首先集中力量从基本专利或市场专卖权到期或即将到期的药物中选一些通用型药物进行口服控释药的...
Andrx, which develops controlled-release generic drugs in the United States, plans to submit 7 to 10 controlled-release generic drugs in the second half of 1994 and the first quarter of 1995 New drug application. The company first focuses on selecting generic drugs for oral controlled release of drugs that expire or are about to expire from the basic patent or market monopoly ...